Howard Hughes Medical Institute’s Dynatrace DT Stock Holding History

Howard Hughes Medical Institute’s Portfolio DT Stock Details DT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-330,000	Closed	-$15.4M	–	3
2023 Q3	$15.4M	Sell	330,000 -700,000	-68%	-$34.4M	78.75%	1
2023 Q2	$53M	Hold	1,030,000	–	–	75.28%	1
2023 Q1	$43.6M	Sell	1,030,000 -262,413	-20%	-$10.6M	77.3%	1
2022 Q4	$49.5M	Hold	1,292,413	–	–	27.56%	1
2022 Q3	$45M	Hold	1,292,413	–	–	12.79%	1
2022 Q2	$51M	Hold	1,292,413	–	–	27.54%	1
2022 Q1	$60.9M	Hold	1,292,413	–	–	26.68%	1
2021 Q4	$78M	Hold	1,292,413	–	–	30.58%	1
2021 Q3	$91.7M	Hold	1,292,413	–	–	30.93%	1
2021 Q2	$75.5M	Hold	1,292,413	–	–	25.25%	1
2021 Q1	$62.3M	Hold	1,292,413	–	–	21.23%	1
2020 Q4	$55.9M	Hold	1,292,413	–	–	13.09%	2
2020 Q3	$53M	Sell	1,292,413 -291,070	-18%	-$11.9M	17.42%	2
2020 Q2	$64.3M	Sell	1,583,483 -403,294	-20%	-$13.3M	26.24%	1
2020 Q1	$47.4M	Sell	1,986,777 -289,127	-13%	-$8.33M	9.93%	4
2019 Q4	$57.6M	Sell	2,275,904 -366,947	-14%	-$8.06M	20.63%	2
2019 Q3	$49.3M	Buy	+2,642,851	New	+$59.9M	13.82%	3

Other funds holding DT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Thoma Bravo Chicago, Illinois $7.28B AUM 35.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Howard Hughes Medical Institute's DT Position: Q4 2023 in Review

Howard Hughes Medical Institute sold out of Dynatrace (DT) in Q4 2023, closing a stake of 330,000 shares — an estimated $15.4M sold.

Howard Hughes Medical Institute first reported a position in DT in Q3 2019 and held it in 17 quarters. The position peaked at $91.7M in Q3 2021. 513 funds tracked by Wall St. Rank hold DT as of Q4 2023.

Howard Hughes Medical Institute reported no remaining Dynatrace position as of Q4 2023 after selling out during the quarter.
Howard Hughes Medical Institute sold 330,000 Dynatrace shares in Q4 2023, an estimated $15.4M.
Howard Hughes Medical Institute first reported a position in Dynatrace in Q3 2019 and held it in 17 quarters.
Howard Hughes Medical Institute's Dynatrace position peaked at $91.7M in Q3 2021.
513 funds tracked by Wall St. Rank held Dynatrace as of Q4 2023.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2023, filed 14 Feb 2024.